IMedEx Rona

About

Q&A

What is IMedEx Rona's primary focus?

IMedEx Rona focuses on providing a non-invasive solution for equitable and reliable urine testing, particularly for underserved populations such as infants, women with disabilities, pregnant women, and individuals with severe obesity.

When was IMedEx Rona founded?

IMedEx Rona was founded in 2022.

Where is IMedEx Rona headquartered?

IMedEx Rona is headquartered in Tel Aviv, Israel.

What is the core technology behind IMedEx Rona's solution?

The core technology includes a biocompatible layer, a novel proprietary design for separation to reduce contamination, an absorbent sponge layer, and a built-in volume indicator, all integrated into a seamless, non-invasive urine collection solution.

What problem does IMedEx Rona aim to solve?

IMedEx Rona aims to address the challenges of urine collection for populations traditionally underserved by standard methods, enhancing healthcare quality, lowering institutional costs, and improving the patient experience through clinical accuracy and patient comfort.

What are the key components of IMedEx Rona's solution?

The solution is based on the synergy between IMedEx Rona and IMedEx MediSqueezer, combining clinical accuracy, patient comfort, and technological innovation for urine testing.

Sectors & technology